Speech therapy in patients with tuberculosis

Not Applicable

• Conditions: Other forms of airway tuberculosis, with bacteriological and histological confirmation / Dysphonia; A15.5

• Registration Number: RBR-9ryj5d
• Lead Sponsor: Instituto Nacional de Infectologia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-08-07
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients who have confirmation of diagnosis of tuberculosis in the upper airways and digestive tract by one or more of the following methods: histopathology, direct examination, culture or PCR; are in attendance at the otorhinolaryngology clinic of INI / FIOCRUZ; consent to participate in the study by signing the consent form.

Exclusion Criteria

Patients younger than 18 years; have speech-language pathology at another institution; present chronic diseases that interfere with the otorhinolaryngological evaluation and / or speech-language therapy, such as head and neck neoplasias, stroke, Central Nervous System tumors, among others; patients with mental problems.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We hope to be able to evaluate the effectiveness of the implementation of speech-language pathology strategies in the care of patients with infectious diseases of mucosal involvement, such as tuberculosis.

Secondary Outcome Measures

Name	Time	Method
We hope that at the end of the drug treatment the patient presents the minimum of functional sequelae, allowing a social reinclusion in the shortest possible time and in the most appropriate way possible.